Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,642,594 papers from all fields of science
Search
Sign In
Create Free Account
Polychemotherapy
Known as:
Polychemotherapies
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Combination Drug Therapy
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.
Kathrin Bauer
,
M. Rancea
,
+4 authors
N. Skoetz
The Cochrane database of systematic reviews
2012
Corpus ID: 205193159
BACKGROUND Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in…
Expand
Highly Cited
2011
Highly Cited
2011
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.
A. von Stackelberg
,
Enrico Völzke
,
+5 authors
G. Tallen
European journal of cancer
2011
Corpus ID: 37379274
2009
2009
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
F. Grange
,
E. Maubec
,
+9 authors
M. D’Incan
Archives of dermatology
2009
Corpus ID: 6696765
I n contrast with most primary cutaneous B-cell lymphomas, primary cutaneous large B-cell lymphomas, leg type (PCLBCLs-LT) are…
Expand
Review
2007
Review
2007
Systemic therapy of disseminated malignant melanoma: an evidence‐based overview of the state‐of‐the‐art in daily routine
D. Nashan
,
M. Müller
,
S. Grabbe
,
S. Wustlich
,
A. Enk
Journal of the European Academy of Dermatology…
2007
Corpus ID: 25026182
Aims In the metastatic stage, malignant melanoma is resistant to systemic treatment and carries a poor prognosis. A critical…
Expand
Highly Cited
2004
Highly Cited
2004
A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy.
C. Engel
,
M. Scholz
,
M. Loeffler
Blood
2004
Corpus ID: 12760092
Moderate intensification of conventional multicycle chemotherapy has recently been shown to improve treatment results in…
Expand
Review
2002
Review
2002
Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer.
R. Jakesz
,
H. Hausmaninger
,
H. Samonigg
European journal of cancer
2002
Corpus ID: 38153857
Review
2001
Review
2001
Taxane/anthracycline combinations: setting a new standard in breast cancer?
J. Nabholtz
,
A. Riva
The oncologist
2001
Corpus ID: 385036
Among the novel chemotherapeutic drugs introduced in the 1990s, the taxanes have emerged as the most powerful compounds in breast…
Expand
Highly Cited
1996
Highly Cited
1996
Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.
N. Lemmers
,
M. Gels
,
+6 authors
H. J. Hoekstra
Journal of clinical oncology : official journal…
1996
Corpus ID: 13326819
PURPOSE Venous access ports (VAPs) can be used to administer polychemotherapy to patients with malignancies. The purpose of this…
Expand
1986
1986
[Polychemotherapy of ovarian cancer via combined intravenous and intraperitoneal routes. Technic and preliminary results].
B. Zylberberg
,
J. Ravina
,
J. Salat-Baroux
,
D. Dormont
,
B. Lipp
,
J. Guillet
Journal de gynecologie, obstetrique et biologie…
1986
Corpus ID: 40307773
20 patients with F.I.G.O. stages III ovarian cancer were entered into a randomised trial between January 1980 and March 1984…
Expand
1982
1982
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
F. Cavalli
,
M. Beer
,
+5 authors
K. Brunner
Schweizerische medizinische Wochenschrift
1982
Corpus ID: 23988131
Since in the treatment of advanced breast cancer chemotherapy and the various hormonal manipulations seem recently to have…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE